Reticulocyte hemoglobin equivalent to detect thalassemia and thalassemic hemoglobin variants

International Journal of Laboratory Hematology

Volumn 34, Issue 6, 2012, Pages 605-613

  Sudmann, Åshild A ^a   Piehler, A ^a,b   Urdal, P ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Furst Medical Laboratory   (Norway)

Author keywords

Ferritin; Hemoglobin; Hemoglobinopathy; RBC; Reticulocytes; Thalassemia

Indexed keywords

FERRITIN; HEMOGLOBIN; GLOBIN;

ADOLESCENT; ADULT; ALGORITHM; ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; BLOOD SAMPLING; CHILD; DIAGNOSTIC VALUE; ERYTHROCYTE COUNT; FEMALE; HEMOGLOBINOPATHY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PRESCHOOL CHILD; PRIORITY JOURNAL; RETICULOCYTE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; THALASSEMIA; ALPHA-THALASSEMIA; BETA-THALASSEMIA; BLOOD; DNA SEQUENCE; GENETICS; HEMOGLOBINOPATHIES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; YOUNG ADULT;

ADOLESCENT; ADULT; ALGORITHMS; ALPHA-THALASSEMIA; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ERYTHROCYTE INDICES; FEMALE; FERRITINS; GLOBINS; HEMOGLOBINOPATHIES; HEMOGLOBINS; HUMANS; INFANT; MALE; REPRODUCIBILITY OF RESULTS; RETICULOCYTES; ROC CURVE; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84873289028     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2012.01442.x     Document Type: Article

References (33)

1. Ryan K, Bain BJ, Worthington D, James J, Plews D, Mason A, Roper D, Rees DC, de la Salle B, Streetly A, British Committee for Standards in Haematology Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol 2010;149:35-49.
2. Weatherall DJ. The Thalassaemia Syndromes. Oxford: Blackwell Science; 2001.
3. Fairbanks VF. Hemoglobinopathies and Thalassemias: Laboratory Methods and Case Studies. NewYork: Decker/Thieme-Stratton; 1980.
4. WHO Iron deficiency Anaemia (chapter 3). In: Comparative Quantification of Health Risks. Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Ezzati M, Lopez AD, Rodgers A, Murray CJL. (eds). Geneva: WHO; 2004: 230.
5. England JM, Fraser PM. Differentiation of iron deficiency from thalassaemia trait by routine blood-count. Lancet 1973;1:449-452.
6. Mentzer WCJ. Differentiation of iron deficiency from thalassaemia trait. Lancet 1973;1:882.
7. Srivastava PC. Differentiation of thalassaemia minor from iron deficiency. Lancet 1973;2:154-155.
8. Shine I, Lal S. A strategy to detect betathalassaemia minor. Lancet 1977;1:692-694.
9. Sirdah M, Tarazi I, Al NE, Al HR. Evaluation of the diagnostic reliability of different RBC indices and formulas in the differentiation of the beta-thalassaemia minor from iron deficiency in Palestinian population. Int J Lab Hematol 2008;30:324-330.
10. Ehsani MA, Shahgholi E, Rahiminejad MS, Seighali F, Rashidi A. A new index for discrimination between iron deficiency anemia and beta-thalassemia minor: results in 284 patients. Pak J Biol Sci 2009;12:473-475.
11. Mast AE, Blinder MA, Dietzen DJ. Reticulocyte hemoglobin content. Am J Hematol 2008;83:307-310.
12. d'Onofrio G, Chirillo R, Zini G, Caenaro G, Tommasi M, Micciulli G. Simultaneous measurement of reticulocyte and red blood cell indices in healthy subjects and patients with microcytic and macrocytic anemia. Blood 1995;85:818-823.
13. Skarmoutsou C, Papassotiriou I, Traeger-Synodinos J, Stamou H, Ladis V, Metaxotou-Mavrommati A, Stamoulakatou A, Kanavakis E. Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin in content. Haematologica 2003;88:631-636.
14. Canals C, Remacha AF, Sarda MP, Piazuelo JM, Royo MT, Romero MA. Clinical utility of the new Sysmex XE 2100 parameter -reticulocyte hemoglobin equivalent -in the diagnosis of anemia. Haematologica 2005;90:1133-1134.
15. Urrechaga E, Borque L, Escanero JF. Potential utility of the new Sysmex XE 5000 red blood cell extended parameters in the study of disorders of iron metabolism. Clin Chem Lab Med 2009;47:1411-1416.
16. Chouliaras GL, Stamoulakatou A, Tsiftis G, Perissaki G, Premetis E, Lycopoulou L. Age, beta thalassaemia trait, and iron-deficient anaemia significantly affect reticulocyte indices in pre-school children. Eur J Pediatr 2010;169:1097-1104.
17. Brugnara C, Laufer MR, Friedman AJ, Bridges K, Platt O. Reticulocyte hemoglobin content (CHr): early indicator of iron deficiency and response to therapy. Blood 1994;83:3100-3101.
18. Fishbane S, Galgano C, Langley RCJ, Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int 1997;52:217-222.
19. Brugnara C. Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit Rev Clin Lab Sci 2000;37: 93-130.
20. Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol 2006;28:303-308.
21. Miwa N, Akiba T, Kimata N, Hamaguchi Y, Arakawa Y, Tamura T, Nitta K, Tsuchiya K. Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency. Int J Lab Hematol 2010;32:248-255.
22. Franck S, Linssen J, Messinger M, Thomas L. Potential utility of Ret-Y in the diagnosis of iron-restricted erythropoiesis. Clin Chem 2004;50:1240-1242.
23. Briggs C, Rogers R, Thompson B, Machin SJ. New red cell parameters on the Sysmex XE-2100 as potential markers of functional iron deficiency. Infusionsther Transfusionsmed 2001;28:256-262.
24. Buttarello M, Temporin V, Ceravolo R, Farina G, Bulian P. The new reticulocyte parameter (RET-Y) of the Sysmex XE 2100: its use in the diagnosis and monitoring of posttreatment sideropenic anemia. Am J Clin Pathol 2004;121:489-495.
25. Thomas L, Franck S, Messinger M, Linssen J, Thome M, Thomas C. Reticulocyte hemoglobin measurement-comparison of two methods in the diagnosis of ironrestricted erythropoiesis. Clin Chem Lab Med 2005;43:1193-1202.
26. Wood WG, Weatherall DJ, Hart GH, Bennett M, Marsh GW. Hematologic changes and hemoglobin analysis in beta thalassemia heterozygotes during the first year of life. Pediat Res 1982;16:286-289.
27. Mayo P, Hartshorne T, Li K, McMunn-Gibson C, Spencer K, Schnetz-Boutaud N. CNV analysis using TaqMan copy number assays. Curr Protoc Hum Genet 2010; (Suppl. 67):2.13.1-2.13.10. Chapter 2: Unit2.13, 2010 Oct. Unit2.
28. Tan AS, Quah TC, Low PS, Chong SS. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for alphathalassemia. Blood 2001;98:250-251.
29. Soldin SJ, Brugnara C, Wong E. Pediatric Reference Intervals. Washington, DC: AACC Press; 2007.
30. Nordin G, Martensson A, Swolin B, Sandberg S, Christensen NJ, Thorsteinsson V, Franzson L, Kairisto V, Savolainen ER. A multicentre study of reference intervals for haemoglobin, basic blood cell counts and erythrocyte indices in the adult population of the Nordic countries. Scand J Clin Lab Invest 2004;64:385-398.
31. Abbassi-Ghanavati M, Greer LG, Cunningham FG. Normal reference ranges in pregnant women. 2010; UpToDate. 3-5-2011. 3-5-2011. Ref Type: Electronic Citation.
32. Gardenghi S, Grady RW, Rivella S. Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in -thalassemia. [Review]. Hematol Oncol Clin North Am 2010;24:1089-1107.
33. Aalandslid V. Innvandreres demografi og levekÅ r i 12 kommuner i Norge. Rapporter 2007/24. 2007; Statistics Norway, 97-98. Ref Type: Electronic Citation.